New management team for FCBCure
Joe Soto and Steven Hebert have been appointed to the roles of co-managing directors for FCBCure, FCB Health’s New Jersey office.
“We are excited to welcome such a talented team to lead FCBCure,” says Dana Maiman, CEO of FCB Health. “Their diverse experience and proven track record, both individually and as a team, will be instrumental in continuing the transformation of our business and the business of our clients.”
Soto and Hebert join FCBCure after spending the past four years together at Saatchi & Saatchi Wellness in Manhattan, where they led account and creative teams, respectively.
“For us the key was always about painting a picture of success, for our clients and our people,” Soto says. “At FCBCure and with the FCB Health family, we have an even bigger canvas to work with.”
The transformation of the former ICC Lowe agencies began 18 months ago with their consolidation and introduction into the FCB Health family of agencies. It continued with the rebrand to FCBCure and the renovation of the agency’s offices, tearing down more 150 walls in the process.
Soto and Hebert will lead a staff of more than 130 in the company’s offices in Parsippany, N.J.
“Talent is a top priority for us,” says Hebert, who heads up the group’s creative offerings. “There’s a lot of great talent that doesn’t live between the Hudson and East rivers. Now they have a home, closer to home, worth entrusting with their careers.”
According to Soto, “FCBCure is an amazing organization, with the best talent from throughout the industry, backed by the full weight of FCB Health.”
Hebert adds, “FCBCure is more than just a name. It is an aspiration, a promise we make to our clients and ourselves. It says that we won’t stop, we won’t relent, we won’t back down until we have solved a problem completely. Our clients deserve nothing less.”
FCBCure is a full-service healthcare agency dedicated to healthcare advertising and promotion for healthcare professionals and consumers across all channels. FCBCure’s client roster includes Allergan, Bayer, DSI, Heron, J&J Vision Care, Ophthotech, and Vertex.
